Clinical Trials Logo

Filter by:
NCT ID: NCT02235103 Completed - Clinical trials for Unexplained Infertility

The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate.

DNAFRAG
Start date: April 2014
Phase: N/A
Study type: Observational

Recent research has revealed that subtle abnormalities can be found in sperm samples that seem to be normal with conventional analysis techniques. The DNA in the sperm heads is sometimes fragmented and this may be the reason why couples with a diagnosis of unexplained infertility do not achieve pregnancy. We are planning a study to examine the incidence of DNA fragmentation in the sperm of couples with previously unexplained infertility. In a first treatment cycle with intra-uterine insemination the percentage of DNA fragmentation in sperm will be measured. Afterwards the results of the patients who are pregnant will be compared with those of the not pregnant ones. We expect to find differences between both groups. 100 patients will be included in the study.

NCT ID: NCT02234843 Completed - Clinical trials for Venous Thromboembolism

EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

EINSTEIN Jr
Start date: November 13, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate comparative efficacy and safety of rivaroxaban to standard of care in children with acute venous thromboembolism.

NCT ID: NCT02234050 Completed - Clinical trials for Recurrent High Grade Meningioma

Trabectedin for Recurrent Grade II/III Meningioma

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to collect data on activity, toxicity and quality of life of trabectedin therapy in patients with recurrent high-grade meningioma.

NCT ID: NCT02232061 Completed - Multiple Sclerosis Clinical Trials

Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks

Start date: September 29, 2014
Phase: Phase 4
Study type: Interventional

This study will evaluate if patients who had a serious cardiovascular event upon initiation of fingolimod are at risk to delevop long term other cardiovascular events

NCT ID: NCT02231489 Completed - Healthy Clinical Trials

Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy Participants

Start date: September 2014
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the relative bioavailability of JNJ-42756493 oral dose of capsule (reference) versus tablet (test) in healthy participants.

NCT ID: NCT02231307 Completed - Clinical trials for Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Start date: September 2014
Phase: Phase 3
Study type: Interventional

The aim of this phase III study is to asses if SUBLIVAC FIX Birch is safe and effective in reducing birch allergy induced symptoms and birch allergy medication usage.

NCT ID: NCT02230852 Completed - Stroke. Clinical Trials

Prehospital Stroke Study at the Universitair Ziekenhuis Brussel I (PreSSUB I)

PreSSUB I
Start date: September 2014
Phase: N/A
Study type: Observational

The PreSSUB trial I will focus on prehospital telemedicine for patients with suspicion of acute stroke. The study is designed as a prospective monocentric observational trial on the safety, feasibility and reliability of in-ambulance telemedicine for patients with suspicion of acute stroke during transportation by the Paramedic Intervention Team of the Universitair Ziekenhuis Brussel.

NCT ID: NCT02228798 Completed - Atrial Fibrillation Clinical Trials

Perioperative Anticoagulant Use for Surgery Evaluation Study

PAUSE
Start date: August 1, 2014
Phase:
Study type: Observational

The aim of the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study, is to establish a safe, standardized protocol for the perioperative management of patients with atrial fibrillation (AF) who are receiving a novel oral anticoagulant (DOAC) drug, either dabigatran, rivaroxaban or apixaban, and require an elective surgery/procedure.

NCT ID: NCT02228551 Completed - Clinical trials for Risk Factors for Augmented Renal Clearance

Augmented Renal Clearance in the Adult Non-critically Ill Surgery Patient: a Prospective Point Prevalance Study

ARCPPS
Start date: November 2013
Phase: N/A
Study type: Interventional

This point prevalence study investigates the prevalence of augmented renal clearance (i.e. a measured 8-hour urinary creatinine clearance >= 120 ml/min/1.73m²) in an adult non-critically ill abdominal and trauma surgery population. Secondary objectives are the identification of risk factors associated with ARC in this specific study population.

NCT ID: NCT02227992 Completed - Hemorrhage Clinical Trials

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Start date: July 1, 2014
Phase: Phase 3
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of EVARRESTâ„¢ Sealant Matrix (EVARRESTâ„¢ Fibrin Sealant Patch) (EVARRESTâ„¢) in controlling mild or moderate soft tissue & parenchymal bleeding during open hepatic, abdominal, pelvic, retroperitoneal, and thoracic (non-cardiac) surgery in paediatric patients.